Examples of 'shows binding' in a sentence
Meaning of "shows binding"
shows binding: This phrase is used to describe a situation where clear evidence or indication of a strong connection or agreement is displayed. It suggests that there is a compelling or undeniable bond or commitment that is evident or demonstrated
How to use "shows binding" in a sentence
Basic
Advanced
shows binding
A shift to the right shows binding.
The upper left picture shows binding of a control phage antibody directed against thyroglobulin.
The abscissa shows concentration of respective peptides ( µg / ml ), and the ordinate shows binding activity ( % ).
The Harlil sequence shows binding specificity to NTP.
Figure 7 shows binding of scFv-CAL fusions to cell surface antigen by confocal fluorescence laser microscopy.
The data point marked with a solid square shows binding achieved at atmospheric pressure after 60 minutes.
Fig 7 Shows binding of antibody-lipase to a nucleotide sequence on a solid phase and subsequent liposomal lysis.
Correspondingly, Figure 3b shows binding of the binding yarn 10.
Figure 5 shows binding of rFVIII to phospholipid monolayer in SPR and inhibition by pdVWF.
Figure 18 ( A ) is a graph which shows binding of purified human PTH to its receptor.
It shows binding to the specific vitamin B12 transport proteins.
The first case ( membrane ) shows binding to a preparation of crude membrane pellets.
Figure 3 shows binding of the BMP antagonist Noggin to sclerostin in an immunoprecipitation assay.
Figure 2 shows binding of astrin to raptor.
Figure 7 shows binding results for both antibodies at a single P-selectin concentration.
See also
Figure 3a shows binding of the binding yarn 9.
Figure 17 shows binding and displacement of the same GHRH analog in ovine pituitary membranes.
Figures 13 shows binding of antibody to PDGFRa.
Step 1 shows binding a single primer to a target RNA.
Figure 32A-C shows binding data for certain constructs.
Figure 8 shows binding of C6PS to Factor IXa as detected by intrinsic fluorescence.
Figure 15A shows binding to activated human T-cells.
Figure 6 shows binding of Kv a subunit T1 domain to the KyB subunit microtitre plate array.
Figure 7 shows binding of plasminogen activators to fibrin.
Figure 9 shows binding of pdVWF and fragment III to heparin.
Figure 7B shows binding to protein fragments derived from denatured FN.
Figure 7A shows binding to protein fragments derived from native FN.
Figure 2 shows binding specificity of four Fab fragments as analysed by ELISA.
FIGURE 3 shows binding of purified IgG to BA peptides and to other peptides.
Figure 8 shows binding of pdVWF and fragment III to collagen type III.
Figure 2 shows binding of the BMP antagonists Chordin Fig.
Figure 8 shows binding of delta-plasminogen to fibrin.
Fig . 14 shows binding activity of each antibody to a human platelet.
Figure 3 shows binding of avidin to biotin and 8-oxoguanine as assessed by capillary electrophoresis.
Figure 5 shows binding of avidin to 8-oxodeoxyguanosine and its unmodified deoxynucleoside analogue.
Figure 32 shows binding specificity after ten selection rounds, including two rounds of backcrossing.
Figure 2 shows binding profiles ( Kd ) for three different SIRPa fusión proteins.
Figure 7B shows binding response of human IgG1 ( a negative control ) to immobilized human VWF.
Figure 4 shows binding of pdVWF, fragment II and III to rFVIII.
FIG . 9 shows binding of pdVWF and fragment III to heparin.
Fig . 5C shows binding of HEM7 to IgE-secreting cells as determined by fluorescence flow cytometry.
Initial RU increase shows binding of P-selectin to biotin-GSP-6 coupled to a streptavidin coated BIACORE chip.
Insert shows binding response compared to control for a single injection of disulphide-linked A6 soluble TCR ;.
FIG . 7A shows binding to protein fragments derived from native FN.
FIG . 7B shows binding to protein fragments derived from denatured FN.
Figure 9 shows binding of human Rantes Chemokine to partially-purified CBP-I.
Figure 7 shows binding curves for SPL2 peptide to Kv B subunit array.
Figure 4 shows binding of Hu4D5 monomers to human FcYRI.
Figure 5 shows binding of Hu4D5 dimers to human FcYRIIB.
Figure 32 shows binding of HSA, single, double and triple mutant variants to shFcRn.
You'll also be interested in:
Examples of using Binding
Show more
Compliance with legally binding regional protocols
Legally binding provisions on availability of unleaded fuel
Adopt rigorous and binding reporting rules
Examples of using Shows
Show more
Each time someone shows that he cares
Shows how paranoid you can get
A confidential analysis shows a downward trend in popularity
